Summit Healthcare will deploy 2bPrecise as part of a precision medicine initiative focused on pharmacogenetics, an area of study dedicated to understanding the role a patient’s genetics plays in their response to different drugs.
Under the program, providers will have access to information about the potential efficacy and safety of various medications based on the individual’s genetic profile available at the point of care. “The use of the 2bPrecise pharmacogenomics platform allows Summit Healthcare to more precisely prescribe patient medications by using the patient’s genetic information to determine medication effectiveness,” Aaron Young, CIO of Summit Healthcare, said in a news release.
For example, one anesthesiologist at Summit Healthcare said pharmacogenetics information could inform up to 80 percent of the decisions that he makes about pre-surgical patient care.
In addition to improving clinical outcomes, Summit Healthcare officials said they expect the program to help the hospital manage costs and meet quality requirements as part of its participation in an ACO.
More articles on health IT:
Facebook backs AI ethics institute with $7.5M
Kelly Cronin — ONC’s 1st-ever employee — to leave agency
Data scientist tops Glassdoor’s 2019 ‘Best Jobs in America’ ranking
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.